Future Health ESG (NASDAQ:FHLT) announced in an 8-K this morning that it has terminated its combination agreement with medical technology company Excelera Health.
This comes just a few weeks after the SPAC mutually terminated its $100 million PIPE and $20 million forward purchase agreement (“FPA”) with Variant Capital and Hakim. At that time, Future Health had stated that it did not expect the termination of the PIPE and the FPA to impact Excelera’s operations or delay the closing of the deal. The SPAC also noted in early October that it was in discussions with investors to secure alternative strategic financing that would have been less dilutive to its stockholders.
But, it appears these discussions did not materialize into anything further as Future Health sent a termination notice to Excelera on October 31. As a result of the termination, the SPAC is not obligated to pay any penalties pursuant to the terms of the business combination agreement or any related agreements. Future Health and Excelera now mark the 50th deal to be terminated this year.
The parties originally announced the $459 million deal on June 14, 2022. Newport Beach, California-based Excelera operates a just-launched network of physicians serving Medicare patients through a direct contracting entity (DCE) model aimed at reducing costs.
Globa Terra Acquisition Corporation (NASDAQ:GTERU) announced the pricing of its $152 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GTERU”, Wednesday, July 9, 2025. The new SPAC plans to mount a search for a target in the agriculture, agtech or biotech sectors with an emphasis on water...
M3-Brigade V (NASDAQ:MBAV) has entered into a definitive agreement to combine with crypto treasury firm ReserveOne, assembling about $1 billion in equity funding. ReserveOne is setting up a diversified Bitcoin and digital asset treasury with a portion of its investments going towards blockchain infrastructure and venture raises. The combined company is expected to trade on...
At the SPAC of Dawn As the SPAC market has warmed in 2025, only 21 of the 70 SPACs (30%) that have IPO’d thus far have overfunded their trusts to draw in investors and none of these funded to more than 101%. By contrast, 87% of 2023 SPACs were overfunded – some to as high...
Emmis Acquisition Corporation (NASDAQ:EMISU) has filed for a $100 million SPAC to take a look at the manufacturing sector after a few unique wrinkles in their IPO process. Initial investors are set to receive one right to a 1/10 share in each unit purchased and the SPAC will have 18 months to complete a business...
Chenghe III (NASDAQ:CHEC.U) has filed for a $110 million SPAC to continue the team’s growing series while turning to a new underwriter. The new SPAC is offering investors a 1/2 warrant in each unit and no overfunding of the trust, but it will need to complete a business combination within 18 months of its IPO...